Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Mepolizumab (SASAM Study)
Clinical trial NCT05040997 · UNKNOWN
Trial details
- NCT number
- NCT05040997
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-05-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.